Congenital toxoplasmosis: Candidate host immune genes relevant for vertical transmission and pathogenesis

Genes and Immunity

Volumn 11, Issue 5, 2010, Pages 363-373

  Ortiz Alegria L B ^a   Caballero Ortega, H ^a   Caedo Solares I ^a   Rico Torres, C P ^a   Sahagun Ruiz A ^b   Medina Escutia, M E ^c   Correa, D ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

congenital toxoplasmosis; host genetics; immune response; polymorphismsToxoplasma gondii

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; FC RECEPTOR; GAMMA INTERFERON; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; CYTOKINE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; CELLULAR IMMUNITY; CONGENITAL TOXOPLASMOSIS; CYTOKINE RESPONSE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMPLANTATION; INDUCED ABORTION; INFECTION CONTROL; INNATE IMMUNITY; MACROPHAGE MIGRATION INHIBITION; MICROENVIRONMENT; NONHUMAN; PARASITE TRANSMISSION; PREGNANCY; PRIORITY JOURNAL; PROTOZOAL GENETICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TACHYZOITE; TH1 CELL; TROPHOBLAST; VERTICAL TRANSMISSION; ADULT; FEMALE; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; TOXOPLASMA;

TOXOPLASMA GONDII; VERTEBRATA;

ADAPTIVE IMMUNITY; ADULT; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POLYMORPHISM, GENETIC; PREGNANCY; RECEPTORS, FC; TH1 CELLS; TOLL-LIKE RECEPTORS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 77954887981     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.21     Document Type: Review

References (102)

1. Montoya JG Liesenfeld O. Toxoplasmosis. Lancet, 2004, 363, 1965-1976.
2. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829-1833.
3. Pepe GJ, Albrecht ED. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995; 16: 608-648.
4. Wilczynski JR. Th1/Th2 cytokines balance-yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol 2005; 122: 136-143.
5. Correa D, Caballero-Ortega H, Rico-Torres CP, Cañedo-Solares I, Ortiz-Alegŕia LB, Becerra-Torres E et al. Immuno-biology of congenital toxoplasmosis. In: Terrazas I (ed). Advances in the Immunobiology of Parasitic Diseases. Research Signpost: Kerala, India, 2007, pp 199-224.
6. Abou-Bacar A, Pfaff AW, Letscher-Bru V, Filisetti D, Rajapakse R, Antoni E et al. Role of gamma interferon and T cells in congenital Toxoplasma transmission. Parasite Immunol 2004; 26: 315-318.
7. Cañedo-Solares I, Galván-Ramírez ML, Luna-Pastén H, Rodríguez-Pérez R, Ortiz-Alegŕia LB, Rico-Torres CP et al. Human congenital toxoplasmosis: specific IgG subclasses in mother/newborn pairs. Pediatr Infect Dis J 2008; 27: 469-474.
8. Denkers EY. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol 2003; 39: 193-203.
9. Mun HS, Aosai F, Norose K, Chen M, Piao LX, Takeuchi O et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 2003; 15: 1081-1087.
10. Yarovinsky F, Sher A. Toll-like receptor recognition of Toxoplasma gondii. Int J Parasitol 2006; 36: 255-259.
11. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998; 11: 569-588.
12. Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwar-zenberger P, Combe C et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 2005; 73: 617-621.
13. Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat Immunol 2000; 1: 83-87.
14. Aliberti J, Valenzuela JG, Carruthers V, Hieny S, Andersen J, Charest H et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 2003; 4: 485-490.
15. Khan IA, Murphy PM, Casciotti L, Schwartzman JD, Collins J, Gao JL et al. Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection. J Immunol 2001; 166: 1930-1937.
16. Benevides L, Milanezi CM, Yamauchi LM, Benjamim CF, Silva JS, Silva NM. CCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system. Am J Pathol 2008; 173: 741-751.
17. Del Rio L, Bennouna S, Salinas J, Denkers EY. CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J Immunol 2001; 167: 6503-6509.
18. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M et al. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 2008; 29: 306-317.
19. Roberts CW, Ferguson DJP, Jebbari H, Satoskar A, Blue-thmann H, Alexander J. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun 1996; 64: 897-904.
20. Alexander J, Jebbari H, Bluethmann H, Brombacher F, Roberts CW. The role of IL-4 in adult acquired and congenital toxoplasmosis. Int J Parasitol 1998; 28: 113-120.
21. Pleass RJ, Woof JM. Fc receptors and immunity to parasites. Trends Parasitol 2001; 17: 545-550.
22. Correa D, Cañ edo-Solares I, Ortiz-Alegría LB, Caballero-Ortega H, Rico-Torres CP. Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host. Parasite Immunol 2007; 29: 651-660.
23. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-g, and TNF-a. J Immunol 1996; 157: 798-805.
24. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunol 2006; 7: 937-945.
25. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 2002; 21: 471-495.
26. Chaouat G, Ledée-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Th1/Th2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the Th1/Th2 paradigm. Int Arch Allergy Immunol 2004; 134: 93-119.
27. Hannan NJ, Salamonsen LA. Role of chemokines in the endometrium and in embryo implantation. Curr Opin Obstet Gynecol 2007; 19: 266-272.
28. He YY, Du MR, Guo PF, He XJ, Zhou WH, Zhu XY et al. Regulation of C-C motif chemokine ligand 2 and its receptor in human decidual stromal cells by pregnancy-associated hormones in early gestation. Hum Reprod 2007; 22: 2733-2742.
29. Fraccaroli L, Alfieri J, Larocca L, Calafat M, Mor G, Leirós CP et al. Potential tolerogenic immune mechanism in a tropho-blast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation. Hum Reprod 2009; 24: 166-175.
30. Jaleel MA, Tsai AC, Sarkar S, Freedman PV, Rubin LP. Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival. Mol Hum Reprod 2004; 10: 901-909.
31. Hannan NJ, Salamonsen LA. CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the tropho-blast: potential roles in human embryo implantation. Biol Reprod 2008; 79: 58-65.
32. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11: 803-811.
33. Moreau P, Faure O, Lefebvre S, Ibrahim EC, O'Brien M, Gourand L et al. Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplant Proc 2001; 33: 2277-2280.
34. Viganò P, Gaffuri B, Somigliana E, Infantino M, Vignali M, Di Blasio AM. Interleukin-10 is produced by human uterine natural killer cells but does not affect their production of interferon-gamma. Mol Hum Reprod 2001; 7: 971-977.
35. Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-b superfamily expression and actions in the endometrium and placenta. Reproduction 2006; 132: 217-232.
36. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007; 29: 95-113.
37. Mack DG, Johnson JJ, Roberts F, Roberts CW, Estes RG, David C et al. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol 1999; 29: 1351-1358.
38. Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A et al. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 2001; 7: 195-200.
39. Hill JA. Cytokines considered critical in pregnancy. Am J Reprod Immunol 1992; 28: 123-126.
40. Lieberman LA, Hunter CA. The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii. Int Rev Immunol 2002; 21: 373-403.
41. Senegas A, Villard O, Neuville A, Marcellin L, Pfaff AW, Steinmetz T et al. Toxoplasma gondii-induced foetal resorption in mice involves interferon-gamma-induced apoptosis and spiral artery dilation at the maternofoetal interface. Int J Parasitol 2009; 39: 481-487.
42. Hampson J, McLaughlin PJ, Johnson PM. Low-affinity receptors for tumor necrosis factor-alpha, interferon-gamma and granulocyte-macrophage colony-stimulating factor are expressed on human placental syncytiotrophoblast. Immu¬nology 1993; 79: 485-490.
43. Bream JH, Ping A, Zhang X, Winkler C, Young HA. A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun 2002; 3: 165-169.
44. Barbosa BF, Silva DAO, Costa IN, Mineo JR, Ferro EAV. BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-g, interleukin-10 and transforming growth factor-b1. Clin Exp Immunol 2008; 151: 536-545.
45. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF et al. Cytokine gene polymorphism in human disease: on-line databases. Suppl 1. Genes Immun 2001; 2: 61-70.
46. Keen LJ. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 2002; 10: 143-146.
47. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RGJ, Huizinga TWJ. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci 1998; 95: 9465-9470.
48. Abou-Bacar A, Pfaff AW, Georges S, Letscher-Bru V, Filisetti D, Villard O et al. Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infect Immun 2004; 72: 1397-1401.
49. Pfaff AW, Georges S, Abou-Bacar A, Letscher-Bru V, Klein JP, Mousli M et al. Toxoplasma gondii regulates ICAM-1 mediated monocyte adhesion to trophoblasts. Immunol Cell Biol 2005; 83: 483-489.
50. Ferro EA, Mineo JR, Ietta F, Bechi N, Romagnoli R, Silva DA et al. Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am J Pathol 2008; 172: 50-58.
51. Barragán A, Brossier F, Sibley LD. Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cell Microbiol 2005; 7: 561-568.
52. Arcuri F, Cintorino M, Vatti R, Carducci A, Liberatori S, Paulesu L. Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts. Biol Reprod 1999; 60: 1299-1303.
53. Xiao J, Garcia-Lloret M, Winkler-Lowen B, Miller R, Simpson K, Guilbert LJ. ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. Am J Pathol 1997; 150: 1845-1860.
54. Ferro EA, Bevilacqua E, Favoreto-Junior S, Silva DA, Mortara RA, Mineo JR. Calomys callosus (Rodentia: Cricetidae) trophoblast cells as host cells to Toxoplasma gondii in early pregnancy. Parasitol Res 1999; 85: 647-654.
55. Ferro EAV, Silva DAO, Bevilacqua E, Mineo JR. Effect of Toxoplasma gondii infection kinetics on trophoblast cell population in Calomys callosus, a model of congenital toxoplasmosis. Infect Immun 2002; 70: 7089-7094.
56. Gaffuri B, Viganò P, Nozza A, Gornati G, Di Blasio AM, Vignali M. Expression of intercellular adhesion molecule-1 messenger ribonucleic acid and protein in human term placental cells and its modulation by pro-inflammatory cytokines (interleukin-1b and tumor necrosis factor a). Biol Reprod 1998; 58: 1003-1008.
57. Craig A, Fernandez-Reyes D, Mesri M, McDowall A, Altieri DC, Hogg N et al. A functional analysis of a natural variant of intercellular adhesión molecule-1 (ICAM-1 Kilifi). Hum Mol Genet 2000; 9: 525-530.
58. Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005; 41: S513-S519.
59. Alexander J, Hunter CA. Immunoregulation during toxo-plasmosis. Chem Immunol 1998; 70: 81-102.
60. Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009; 1792: 163-172.
61. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM. CCR5 promoter polymorph¬ism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 1998; 352: 866-870.
62. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000; 287: 2274-2277.
63. Sahagun-Ruiz A, Colla JS, Juhn J, Gao JL, Murphy P, McDermott DH. Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRl1R. Genes Immun 2001; 2: 335-342.
64. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, Combe C et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2006; 2: 484-500.
65. Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Venturelli E et al. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease. J Neurol Sci 225: 79-83.
66. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-377.
67. Pedersen BR, Kamwendo D, Blood M, Mwapasa V, Moly-neux M, North K et al. CCR5 haplotypes and mother-to-child HIV transmission in Malawi. PLoS One 2007; 2: e838.
68. Watanabe K, Iwai N, Tachibana M, Furuoka H, Suzuki H, Watarai M. Regulated upon activation normal T-cell ex¬pressed and secreted (RANTES) contributes to abortion caused by Brucella abortus infection in pregnant mice. J Vet Med Sci 2008; 70: 681-686.
69. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci 1999; 96: 4581-4585.
70. Zhernakova A, Alizadeh BZ, Eerligh P, Hanifi-Moghaddam P, Schloot NC, Diosdado B et al. Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes. Genes Immun 2006; 7: 544-549.
71. Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite induced IL-12 production by dendritic cells. J Immunol 2002; 168: 5997-6001.
72. Gazzinelli RT, Denkers EY. Protozoan encounters with Toll¬like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 2006; 6: 895-906.
73. Ma Y, Krikun G, Abrahams VM, Mor G, Guller S. Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection. Placenta 2007; 28: 1024-1031.
74. Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA. Expression and activity of Toll-like receptor 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod 2009; 80: 243-248.
75. Krediet TG, Wiertsema SP, Vossers MJ, Hoeks SB, Fleer A, Ruven HJ et al. Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res 2007; 4: 474-476.
76. Schmitt C, Humeny A, Becker CM, Brune K, Pahl A. Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem 2002; 48: 1661-1667.
77. Schwartz DA, Cook DN. Polimorphisms of the Toll-like receptors and human disease. Clin Infect Dis 2005; 41: S403-S407.
78. de Moraes-Pinto MI, Vince GS, Flanagan BF, Hart CA, Johnson PM. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic mem¬branes. Immunology 1997; 90: 87-94.
79. Gonzales JR, Gröger S, Haley G, Bödeker RH, Meyle J. The interleukin-4-34TT and-590TT genotype is correlated with increased expression and protein production in aggressive periodontitis. Mol Immunol 2010; 4: 701-705.
80. Street ME, Seghini P, Ziveri MA, Fieni S, Volta C, Neri TM et al. Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation. Growth Horm IGF Res 2006; 16: 365-372.
81. Foster CB, Lehrnbecher T, Samuels S, Stein S, Mol F, Metcalf JA et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000; 96: 2562-2567.
82. Saji F, Samejima Y, Kamiura S, Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. Rev Reprod 1999; 4: 81-89.
83. Cederqvist LL, Ewool LC, Bonsnes RW, Litwin SD. Detectability and pattern of immunoglobulins in normal amniotic fluid throughout gestation. Am J Obstet Gynecol 1978; 15: 220-224.
84. McLeod R, Dowel M. Basic immunology: the fetus and the newborn. In: Ambroise-Thomas P, Petersen E (eds). Con¬genital Toxoplasmosis: Scientific Background, Clinical Manage¬ment and Control. Springer-Verlag: France, 2000, pp 37-68.
85. de Lange GG. Polymorphisms of human immunoglobulins: Gm, Am, Em and Km allotypes. Exp Clin Immunogenet 1989; 6: 7-17.
86. Cerutti N, Dugoujon JM, Guitard E, Rabino Massa E. Gm and Km immunoglobulin allotypes in Sicily. Immunogenetics 2004; 55: 674-681.
87. Pandey JP, French MA. Gm phenotypes influence the concentrations of the four subclasses of immunoglobulin G in normal human serum. Hum Immunol 1996; 51: 99-102.
88. Capel PJA, van de Winkel JGJ, van den Herik-Oudijk IE, Verbeek JS. Heterogeneity of human IgG Fc receptors. Immunomethods 1994; 4: 25-34.
89. van de Winkel JGJ, Capel PJA. Overview: Fc receptors. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 1993; 14: 215-221.
90. Parren PWH, Warmerdam PAM, Boeije LCM, Arts J, Westerdaal NAC, Vlug A et al. On the interaction of IgG subclasses with the low affinity FcgRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a func¬tional polymorphism to human IgG2. J Clin Invest 1992; 90: 1537-1546.
91. Salmon JE, Edberg JC, Brogle NL, Kimberly RP. Allelic polymorphisms of human Fcg receptor IIA and Fcg receptor IIIB independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89: 1274-1281.
92. de Haas M, Koene HR, Kleijer M, de Vries E, Simsek S, van Tol MJ et al. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa. J Immunol 1996; 156: 2948-2955.
93. Ory PA, Clark MR, Kwoh EE, Clarkson SB, Goldstein IM. Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J Clin Invest 1989; 84: 1688-1691.
94. Simister NE, Story CM. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J Reprod Immunol 1997; 37: 1-23.
95. Bright NA, Ockleford CD, Anwar M. Ontogeny and distribution of Fc gamma receptors in the human placenta. Transport or immune surveillance? J Anat 1994; 184: 297-308.
96. Sachs UH, Socher I, Braeunlich CG, Kroll H, Bein G, Santoso S. A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor a-chain promoter. Immunology 2006; 119: 83-89.
97. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 2006; 168: 1210-1226.
98. Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW et al. FcaRI (CD89) alleles determine the proinflammatory poten¬tial of serum IgA. J Immunol 2007; 178: 3973-3982.
99. Kanada S, Nakano N, Potaczek DP, Maeda K, Shimokawa N, Niwa Y et al. Two different transcription factors discriminate the-315C4T polymorphism of the Fc epsilon RI alpha gene: binding of Sp1 to-315C and of a high mobility group-related molecule to-315T. J Immunol 2008; 180: 8204-8210. 100.
100. Djurkovic-Djakovic O, Roman S, Nobre R, Couvreur J, Thulliez P. Serologic rebounds after one-year-long treatment for congenital toxoplasmosis. Pediatr Infect Dis J 2000; 19: 81-83.
101. Wallon M, Cozon G, Ecocherd R, Lewin P, Peyron F. Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur J Pediatr 2001; 160: 534-540.
102. Jamieson SE, de Roubaix LA, Cortina-Borja M, Tan HK, Mui EJ, Cordell HJ et al. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital tox-oplasmosis. PLoS One 2008; 3: e2285.